Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 8—August 2005

Research

Cephalosporin-resistant Pneumococci and Sickle Cell Disease

Martha L. Miller*1, Caroline A. Obert*1, Geli Gao*, Najat C. Daw*, Patricia Flynn*, and Elaine Tuomanen*Comments to Author 
Author affiliations: *St. Jude Children's Research Hospital, Memphis, Tennessee, USA

Main Article

Table 2

Multilocus sequence types of penicillin- and cephalosporin-resistant isolates*

Strain Serotype Allele numbers
 Sequence type Resistance
 MIC values
aroE gdh gki recP spi xpt ddl PNV CTX PNV CTX
38 3 8 37 9 29 2 12 NA Novel I S 0.38 0.50
3 3 7 15 2 10 6 1 22 180 S
52 4 10 5 4 5 13 10 18 205 S
46 4 10 5 4 5 13 10 18 205 S
61 4 16 13 4 4 6 10 18 899 S
48 6 8 37 9 29 2 12 53 344 I S 0.38 0.19
1 6 7 6 9 2 6 1 67 384 I I 1.00 0.75
49 6 5 7 4 10 10 1 27 460 I NA 0.38
63 6 5 7 4 10 10 1 27 460 I S 0.38 0.50
35 6 1 25 1 8 15 20 14 660 I I 1.00 0.75
81 6 1 25 72 1 15 20 28 690 I S 0.094 0.094
84 6 2 13 8 6 6 3 NA 1754 I NA 0.25
75 6 7 25 4 4 15 20 NA Novel I S 0.094 0.094
13 6 1 5 4 5 5 3 101 NT3 I S 0.38 0.19
29 6 1 5 4 5 5 3 101 NT3 I S 0.94 0.25
19 6 7 6 9 2 6 1 67 384 R R 3.00 3.00
33 6 7 6 1 2 6 15 14 146 S
37 6 7 6 1 2 6 15 14 146 S
40 6 7 6 1 2 6 15 14 146 S
45 6 7 6 1 2 6 15 14 146 S
39 6 7 13 8 6 10 6 14 176 S
76 6 7 15 2 10 6 1 22 180 S
44 6 1 5 1 5 1 1 8 425 S
85 6 7 25 4 4 15 20 1 647 S
30 6 1 25 72 1 15 20 28 690 S
43 6 1 25 72 1 15 20 28 690 S
31 6 7 61 1 1 17 1 NA 1752 S
4 11 2 5 29 12 16 3 14 62 S
20 11 2 5 29 12 16 3 14 62 S
22 14 2 8 7 4 6 1 1 67 R I 4.00 1.00
27 14 2 8 7 4 6 1 1 67 R I 4.00 1.00
57 14 2 8 7 4 6 1 1 67 R I 2.00 1.00
59 14 2 8 7 4 6 1 1 67 R I 3.00 1.50
74 14 1 5 4 5 5 27 8 13 S
56 14 7 5 1 8 14 11 14 124 S
83 14 7 5 1 8 14 11 14 124 S
28 15 8 6 14 4 17 4 14 1755 S
69 15 8 13 1 4 17 4 14 1757 S
71 15 8 13 1 4 17 4 14 1757 S
60 19 8 13 14 4 17 4 14 199 I S 0.125 0.064
70 19 8 13 14 4 17 4 14 199 I S 0.190 0.094
79 19 8 13 14 4 17 4 14 199 I S 0.125 0.064
80 19 8 13 14 4 17 4 14 199 I S 0.094 0.064
24 19 15 16 19 15 6 20 26 236 I S 0.25 0.25
34 19 15 16 19 15 6 20 26 236 I S 0.25 0.25
65 19 15 16 19 15 6 20 26 236 I I 1.00 0.75
42 19 8 20 14 4 17 4 14 1756 I S 0.190 0.094
77 19 8 20 14 4 17 4 14 1756 I S 0.125 0.094
78 19 8 20 14 4 17 4 14 1756 I S 0.190 0.064
41 19 15 NA NA NA 6 NA NA Novel I S 0.25 0.19
32 19 1 10 4 1 9 3 8 43 S
15 19 8 13 14 4 6 4 14 876 S
68 22 1 1 4 1 18 58 17 433 S
2 23 1 8 6 2 6 4 6 37 I R 1.00 1.50
53 23 1 8 6 2 6 4 6 37 I R 0.125 1.50
26 23 1 8 6 2 6 4 6 37 R R 4.00 6.00
47 23 1 8 6 2 6 4 6 37 R R 8.00 8.00
62 23 1 8 6 2 6 4 6 37 R R 3.00 8.00
58 23 1 8 6 2 6 4 NA 1753 R R 3.00 8.00
86 23 1 8 9 2 6 4 6 439 S
14 23 13 8 9 2 6 4 6 1499 S
55 ND 29 33 19 1 36 22 31 447 S
66 ND 5 5 6 1 9 10 14 547 S
25 ND 7 9 NA 1 14 48 14 Novel S

*PNV, penicillin V; CTX, cefotaxime; S, susceptible; I, intermediate; R, resistant; NT, nontypeable; NA, not available; ND, not done.

Main Article

1These authors contributed equally to this study.

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO